We noted a significant decrease in tumor-infiltrating CD3e+ T cells (P = .03), CD8a+ T cells (P = .03), and PD-1+ cells (P = .03) in post-ICI samples, compared with pre-ICI samples (Fig 4). Here, CD3E is linked to neoplasm.